Citigroup’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-25,619
| Closed | -$617K | – | 5076 |
|
|
2023
Q1 | $617K | Buy |
25,619
+15,571
| +155% | +$375K | ﹤0.01% | 2383 |
|
|
2022
Q4 | $106K | Buy |
10,048
+6,959
| +225% | +$73.6K | ﹤0.01% | 3317 |
|
|
2022
Q3 | $14K | Sell |
3,089
-3,120
| -50% | -$14.1K | ﹤0.01% | 4161 |
|
|
2022
Q2 | $24K | Sell |
6,209
-5,236
| -46% | -$20.2K | ﹤0.01% | 4208 |
|
|
2022
Q1 | $84K | Sell |
11,445
-7,008
| -38% | -$51.4K | ﹤0.01% | 3811 |
|
|
2021
Q4 | $104K | Sell |
18,453
-34,315
| -65% | -$193K | ﹤0.01% | 3952 |
|
|
2021
Q3 | $338K | Buy |
52,768
+34,394
| +187% | +$220K | ﹤0.01% | 3149 |
|
|
2021
Q2 | $155K | Buy |
18,374
+8,504
| +86% | +$71.7K | ﹤0.01% | 3680 |
|
|
2021
Q1 | $104K | Sell |
9,870
-4,846
| -33% | -$51.1K | ﹤0.01% | 3682 |
|
|
2020
Q4 | $249K | Buy |
14,716
+6,288
| +75% | +$106K | ﹤0.01% | 3107 |
|
|
2020
Q3 | $108K | Sell |
8,428
-571,894
| -99% | -$7.33M | ﹤0.01% | 3098 |
|
|
2020
Q2 | $8.19M | Buy |
580,322
+567,271
| +4,347% | +$8M | 0.01% | 867 |
|
|
2020
Q1 | $120K | Buy |
13,051
+9,408
| +258% | +$86.5K | ﹤0.01% | 3183 |
|
|
2019
Q4 | $54K | Buy |
+3,643
| New | +$54K | ﹤0.01% | 3913 |
|